Patient‐Reported Symptom Control of Diarrhea and Flushing in Patients With Neuroendocrine Tumors Treated With Lanreotide Depot/Autogel: Results From a Randomized, Placebo‐Controlled, Double‐Blind and 32‐Week Open‐Label Study

Oncologist - United States
doi 10.1634/theoncologist.2017-0284

Related search